Candel Therapeutics (CADL) Interest Coverage Ratio (2022 - 2023)

Historic Interest Coverage Ratio for Candel Therapeutics (CADL) over the last 2 years, with Q4 2023 value amounting to 2.28.

  • Candel Therapeutics' Interest Coverage Ratio rose 11629.8% to 2.28 in Q4 2023 from the same period last year, while for Dec 2023 it was 14.79, marking a year-over-year increase of 16527.68%. This contributed to the annual value of 15.97 for FY2024, which is 792.72% up from last year.
  • Candel Therapeutics' Interest Coverage Ratio amounted to 2.28 in Q4 2023, which was up 11629.8% from 13.25 recorded in Q3 2023.
  • Candel Therapeutics' 5-year Interest Coverage Ratio high stood at 2.28 for Q4 2023, and its period low was 20.12 during Q2 2022.